Brief: Senzime Q3 Sales Up At SEK 30.1 Million
BRIEF-Senzime Q3 Sales Up At SEK 30.1 Million Oct 29 (Reuters) - Senzime AB (publ) SEZI.ST:
Q3 SALES SEK 30.099 MILLION
Q3 ADJUSTED GROSS MARGIN 74%
Q3 OPERATING EXPENSES SEK 31.039 MILLION
Q3 EPS SEK -0.07
Q3 EBITDA SEK -8.026 MILLION
KEY DRIVER WAS INCREASE IN RECURRING SALES OF DISPOSABLE SENSORS
TARGET OF ACHIEVING POSITIVE CASH FLOW WITHIN Q4 OF 2026 REMAINS UNCHANGED
LONG-TERM OUTLOOK FOR MARKET REMAINS VERY POSITIVE, WITH AN ESTIMATED 80,000 EMG-BASED NEUROMUSCULAR MONITORS EXPECTED TO BE IN USE WORLDWIDE OVER NEXT DECADE
Source text: ID:nMFN9tdcPd
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Q3 Sales Up At SEK 30.1 Million
Sweden's Senzime Q3 sales rise on strong sensor demand
Brief: Senzime Reaffirms Target Of Positive Cash Flow In Q4 2026
Brief: Senzime Announces New Non-Dilutive Credit Facility Of SEK 35 Mln
Brief: Senzime Wins Additional Major US Hospital Network Contract